« Previous
Next »
Heart & Lung: The Journal of Acute and Critical Care
Volume 38, Issue 3
, Pages 174-175
, May 2009
Chlamydia pneumonia: An innocent bystander or a major mediator of inflammation in the development of coronary artery disease?
References
- . Evidence for infectious agents in cardiovascular disease and atherosclerosis. Lancet Infect Dis. 2002;2:11–17
- . Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol. 1998;32:35–41
- Chlamydia pneumoniae IgG titers and coronary heart disease: prospective study and meta-analysis. BMJ. 2000;321:208–213
- . Circulating chlamydia pneumonia DNA as a predictor of coronary artery disease. J Am Coll Cardiol. 1999;34:1435–1439
- Pesonen E, Tiirola T, et al. Serum chlamydia lipopolysaccharide as a prognostic factor for a new cardiovascular event. Heart & Lung .
- Novel enzyme immunoassay utilizing lipopolysaccharide-binding protein as a capture molecule for the measurement of chlamydial lipopolysaccharide in serum. Diagn Microbiol Infect Dis. 2006;54:7–12
PII: S0147-9563(08)00136-2
doi: 10.1016/j.hrtlng.2008.07.004
© 2009 Mosby, Inc. All rights reserved.
« Previous
Next »
Heart & Lung: The Journal of Acute and Critical Care
Volume 38, Issue 3
, Pages 174-175
, May 2009
